+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Fertility Testing Devices Research and Forecast 2018-2023

  • ID: 4700787
  • Report
  • October 2018
  • Region: Global
  • Orion Market Research Private Limited
until Mar 31st 2020
1 of 3


  • Abbott Laboratories Inc.
  • Biozhena Corporation
  • Eli Lilly And Company
  • Fairhaven Health, Llc
  • Geratherm Medical Ag
  • Merck Kgaa
  • MORE
Fertility testing devices are electronic devices which are used to monitor and analyze the changes in hormone level in urine, body temperature, saliva, and other samples to predict the or detect the fertility of the user. The devices can be for male fertility testing or female fertility testing, moreover, the devices are ovulation testing device, diagnostic testing device, fertility monitoring devices and so on. These devices are used by clinics, hospital, and individuals for the detection of fertility in user. The decreasing fertility rate in female and availability of such devices and kits on online websites and portal is the major driving factor for this market. There as various e-commerce websites such as Amazon and Alibaba are providing this device online to deliver the services associated with such kits. Additionally, the adoption of the point of care devices and the increasing prevalence of ovarian diseases are the key attributing factor for fueling the growth of fertility testing devices market.

Increasing use of mobile applications and websites for ovulation tracking is the major restraining factor for this market. in addition, the cost of ovulation monitoring devices is high which further hampers the growth of the market. However, pharma healthcare firms are investing in the manufacturing of fertility testing devices that will turn out to be a huge opportunity for this market. additionally, government policies and schemes for the treatment of infertility will further fuel the market in the coming years.

Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. Factors such as the prevalence of polycystic ovarian disease and consumption of alcohol and smoke products in the US fuels the growth of the North American region. However, stringent regulatory policy or the approval of medical devices in this region affect the market growth. Moreover, Asia Pacific is expected to witness the highest growth rate in the global fertility testing market. The increasing infertility cases due to the lifestyle disorder is the major factor for the growth of this market in the Asia Pacific.

There are many companies which are in Fertility Testing devices market such as Abbott Laboratories, bioMérieux SA, Biozhena Corporation, Church & Dwight Co., Inc., Fairhaven Health, Gemc Technology Group Co. Ltd, and so on. The companies are working on developing innovative fertility testing devices and research and innovation, expansion M&A, finding a new market or innovate in their core competency in order to expand individual market share.

Research methodology

The market study of Fertility Testing devices market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include
  • Financial reports of companies involved in the market
  • Authentic Public Databases such as the OICA, OECD, WHO and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalogue.
The Report is intended for Fertility Testing device manufacturer, Investing companies, Government Organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market segmentation

Global Fertility Testing devices market is segmented on the basis of regional outlook and following segments:

1. Global Fertility Testing Devices Market Research and Analysis, By Type

2. Global Fertility Testing Devices Market Research and Analysis, By Regulatory Classification

3. Global Fertility Testing Devices Market Research and Analysis, By End User

The Report Covers:
  • Comprehensive research methodology of global fertility testing devices market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global fertility testing devices market.
  • Insights about market determinants which are stimulating the global fertility testing devices market
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • Abbott Laboratories Inc.
  • Biozhena Corporation
  • Eli Lilly And Company
  • Fairhaven Health, Llc
  • Geratherm Medical Ag
  • Merck Kgaa
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulation
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India

3. Market Determinant
3.1. Motivators
3.1.1. Decreasing Fertility Rate Due to Changing Lifestyles of Women
3.1.2. Adoption of Point of Care Devices
3.1.3. Increasing Prevalence of Polycystic Ovarian Diseases
3.1.4. Rising Average Age of Conceiving in Women
3.2. Restraints
3.2.1. Increasing Use of Mobile Applications and Websites for Ovulation Tracking
3.2.2. High Cost of Ovulation Monitors
3.3. Opportunities
3.3.1. Investment By Healthcare Companies for Manufacturing Fertility Devices
3.3.2. Government Policies & Schemes for Infertility Treatment
3.3.3. Increasing Medical Tourism

4. Market Segmentation
4.1. Global Fertility Testing Device Market, By Type
4.1.1. Female Fertility Testing Ovulation Testing Device Fertility Monitoring Device
4.1.2. Male Fertility Testing
4.1. Global Fertility Testing Device Market, By Regulatory Classification
4.1.1. Over-The-Counter (OTC)
4.1.2. Prescription (Rx)
4.2. Global Fertility Testing Device Market, By End User
4.2.1. Hospitals and Clinics
4.2.2. Home Care

5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North American
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Spain
6.2.4. France
6.2.5. Italy
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of The World

7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Alere Inc.
7.3. Biomérieux S.A
7.4. Biozhena Corporation
7.5. Church & Dwight Co, Inc.
7.6. Cook Medical Inc.
7.7. Eli Lilly and Company
7.8. Endo International Plc
7.9. Esco Micro Pte. Ltd.
7.10. Fairhaven Health, Llc
7.11. Fertility Focus Limited
7.12. Gemc Technology Group Ltd
7.13. Geratherm Medical Ag
7.14. Glaxosmithkline Plc
7.15. Janssen Pharmaceutica Nv
7.16. Merck Kgaa
7.17. Novartis International Ag
7.18. Pfizer Inc.
7.19. Taidoc Technology Corp
7.20. Vivus Inc.
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Abbott Laboratories Inc.
  • Alere Inc.
  • Biomérieux S.A
  • Biozhena Corporation
  • Church & Dwight Co, Inc.
  • Cook Medical Inc.
  • Eli Lilly And Company
  • Endo International Plc
  • Esco Micro Pte. Ltd.
  • Fairhaven Health, Llc
  • Fertility Focus Limited
  • Gemc Technology Group Ltd
  • Geratherm Medical Ag
  • Glaxosmithkline Plc
  • Janssen Pharmaceutica Nv
  • Merck Kgaa
  • Novartis International Ag
  • Pfizer Inc.
  • Taidoc Technology Corp
  • Vivus Inc.
Note: Product cover images may vary from those shown